AI Verdict
PAY has stronger fundamentals based on our AI analysis.
PBH vs PAY Fundamental Comparison
| Metric | PBH | PAY |
|---|---|---|
| Revenue | $807.1M | $1.2B |
| Net Income | $136.4M | $66.9M |
| Net Margin | 16.9% | 5.6% |
| ROE | 7.5% | 11.9% |
| ROA | 3.9% | 10.0% |
| Current Ratio | 3.11x | 4.46x |
| Debt/Equity | 0.56x | 0.00x |
| EPS | $2.78 | $0.52 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PBH vs PAY: Frequently Asked Questions
Is PBH or PAY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PAY has stronger fundamentals. PBH is rated BUY (65% confidence) while PAY is rated BUY (68% confidence). This is not investment advice.
How does PBH compare to PAY fundamentally?
Prestige Consumer Healthcare Inc. has ROE of 7.5% vs Paymentus Holdings, Inc.'s 11.9%. Net margins are 16.9% vs 5.6% respectively.
Which stock pays higher dividends, PBH or PAY?
PBH has a dividend yield of N/A or no dividend while PAY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PBH or PAY for long term?
For long-term investing, consider that PBH has BUY rating with 65% confidence, while PAY has BUY rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PBH vs PAY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PBH vs PAY, the AI consensus favors PAY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.